Benjamin Diamond, MD

Articles by Benjamin Diamond, MD

Benjamin Diamond, MD, of Memorial Sloan Kettering Cancer Center

Dr. Diamond on the Need to Integrate MRD Testing Into Clinical Trials in Multiple Myeloma

ByBenjamin Diamond, MD

May 21st 2021

Benjamin Diamond, MD, discusses the need to integrate minimal residual disease testing into clinical trials in multiple myeloma.

Benjamin Diamond, MD, discusses the rationale for examining long-term minimal residual disease in patients with multiple myeloma.

Dr. Diamond on the Rationale for Examining Long-Term MRD in Myeloma

ByBenjamin Diamond, MD

May 5th 2021

Benjamin Diamond, MD, discusses the rationale for examining long-term minimal residual disease in patients with multiple myeloma.

Latest Updated Articles

Dr. Diamond on the Rationale for Examining Long-Term MRD in Myeloma
May 5th 2021
Dr. Diamond on the Need to Integrate MRD Testing Into Clinical Trials in Multiple Myeloma
May 21st 2021

Trending on OncLive

RELATIVITY-1093 Trial Aims to Advance Nivolumab Plus Relatlimab and Chemo in Nonsquamous NSCLC

Dostarlimab Monotherapy Elicits Durable cCRs in dMMR/MSI-H Locally Advanced Rectal Cancer

NEXERA-303 Trial Aims to Bring TGFβR2×PD-1 Bispecific Antibody INCA33890 Into First-Line MSS CRC

The OncFive: Top Oncology Articles for the Week of 10/25

Dr Gatti on the Prognostic Impact of ESR1 Mutations and Co-Alterations in Breast Cancer